Sanofi lifts profit outlook as Dupixent sales surge over 43%

Sanofi logo at the company’s headquarters during the annual results news conference in Paris, France, February 4, 2022. REUTERS/Benoit Tessier/ Register now for FREE unlimited access to Register July 28 (Reuters) – French healthcare group Sanofi (SASY.PA) lifted its full-year earnings outlook on continued strong sales growth for its bestselling drug Dupixent. In a … Read more